Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients
ClinicalTrials.gov study NCT02424344. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
ClinicalTrials.gov study NCT03569293. IPD Sharing: YES. Countries: 25. Publications: 13.
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
ClinicalTrials.gov study NCT03535194. IPD Sharing: YES. Countries: 16. Publications: 1.
A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19
ClinicalTrials.gov study NCT04822701. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
ClinicalTrials.gov study NCT04242446. IPD Sharing: YES. Countries: 15. Publications: 5.
Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01471171. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
ClinicalTrials.gov study NCT06220604. IPD Sharing: YES. Countries: 11. Publications: 1.
Tafenoquine in Patients With Mild to Moderate COVID-19
ClinicalTrials.gov study NCT04533347. IPD Sharing: NO. Countries: 1. Publications: 10.
A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
ClinicalTrials.gov study NCT03628924. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
ClinicalTrials.gov study NCT06860659. IPD Sharing: NO. Countries: 1. Publications: 23.
Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee
ClinicalTrials.gov study NCT02697773. IPD Sharing: YES. Countries: 3. Publications: 17.
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)
ClinicalTrials.gov study NCT03945019. IPD Sharing: Not stated. Countries: 26. Publications: 2.
A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee
ClinicalTrials.gov study NCT00669409. IPD Sharing: YES. Countries: 1. Publications: 1.
Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients
ClinicalTrials.gov study NCT04388254. IPD Sharing: NO. Countries: 2. Publications: 4.
A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD
ClinicalTrials.gov study NCT05004688. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00307437. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04598269. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
ClinicalTrials.gov study NCT01064414. IPD Sharing: Not stated. Countries: 18. Publications: 3.
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
ClinicalTrials.gov study NCT02864498. IPD Sharing: Not stated. Countries: 2. Publications: 21.
Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD
ClinicalTrials.gov study NCT02603393. IPD Sharing: Not stated. Countries: 21. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.